← Back to Search

N/A

Burn: blood collection for Burns

N/A
Waitlist Available
Led By Jon Simmons, MD
Research Sponsored by University of South Alabama
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 1 year to assess outcome measure
Awards & highlights
No Placebo-Only Group

Summary

This trial will study whether or not levels of mitochondrial dysfunction can be measured in the blood and whether or not this is a predictor of organ failure in burn and trauma patients.

Eligible Conditions
  • Burns
  • Trauma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 1 year to assess outcome measure
This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 1 year to assess outcome measure for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Plasma mtDNA DAMPs concentration

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Group I: trauma: blood collectionExperimental Treatment1 Intervention
blood to be collected at different time intervals. Blood draw as the intervention
Group II: healthy volunteers: blood collectionExperimental Treatment1 Intervention
Blood draws as the intervention
Group III: Burn: blood collectionExperimental Treatment1 Intervention
Procedure: Blood draws as the intervention.

Find a Location

Who is running the clinical trial?

University of South AlabamaLead Sponsor
43 Previous Clinical Trials
15,894 Total Patients Enrolled
1 Trials studying Burns
Jon Simmons, MDPrincipal Investigator - University of South Alabama, Department of Surgery
University of South Alabama Medical Center, Usa Health Physician Billing Services Llc
~4 spots leftby Nov 2025